SG Americas Securities LLC Takes $10.40 Million Position in Omada Health, Inc. $OMDA

SG Americas Securities LLC bought a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 827,447 shares of the company’s stock, valued at approximately $10,401,000.

Several other large investors also recently made changes to their positions in the business. Geode Capital Management LLC acquired a new position in shares of Omada Health in the 2nd quarter worth approximately $637,000. Walleye Capital LLC acquired a new stake in shares of Omada Health during the 2nd quarter valued at $458,000. Ilex Capital Partners UK LLP bought a new stake in shares of Omada Health during the 2nd quarter worth $201,000. Soros Fund Management LLC acquired a new stake in shares of Omada Health during the second quarter worth $640,000. Finally, Raymond James Financial Inc. acquired a new stake in shares of Omada Health during the second quarter worth $32,000.

Insider Buying and Selling at Omada Health

In other Omada Health news, CFO Steven L. Cook sold 2,600 shares of Omada Health stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $19.02, for a total value of $49,452.00. Following the completion of the sale, the chief financial officer directly owned 166,659 shares in the company, valued at $3,169,854.18. The trade was a 1.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Wei-Li Shao sold 4,589 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $17.24, for a total transaction of $79,114.36. Following the transaction, the president owned 316,238 shares in the company, valued at $5,451,943.12. This represents a 1.43% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 78,346 shares of company stock valued at $1,411,799 over the last three months. 6.38% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the company. Citigroup reiterated an “outperform” rating on shares of Omada Health in a research report on Friday, May 8th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. BMO Capital Markets decreased their target price on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, March 6th. Wall Street Zen upgraded shares of Omada Health from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Wells Fargo & Company upped their price target on shares of Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Ten research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $22.91.

Omada Health Trading Up 10.5%

OMDA opened at $20.89 on Friday. The stock has a fifty day moving average price of $16.51 and a 200 day moving average price of $14.85. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The stock has a market cap of $1.24 billion and a price-to-earnings ratio of -77.37.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million for the quarter. As a group, sell-side analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.